BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Surg Proced. May 21, 2019; 9(1): 1-6
Published online May 21, 2019. doi: 10.5412/wjsp.v9.i1.1
Role of botulinum toxin a in the management of complex incisional hernias
Christos Farazi-Chongouki, Dimitrios Filippou
Christos Farazi-Chongouki, Dimitrios Filippou, Department of Anatomy and Surgical Anatomy, Medical School, National and Kapodestrian University of Athens, Athens 11521, Greece
Author contributions: Farazi-Chongouki C and Filippou D conceived the study and drafted the manuscript; both authors approved the final version of the article.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Corresponding author: Dimitrios Filippou, MD, PhD, Assistant Professor, Department of Anatomy and Surgical Anatomy, Medical School, National and Kapodestrian University of Athens, 22 D. Soutsou Street, Athens 11521, Greece. d_filippou@hotmail.com
Telephone: +30-6944-287125
Received: February 22, 2019
Peer-review started: February 26, 2019
First decision: March 25, 2019
Revised: April 1, 2019
Accepted: April 26, 2019
Article in press: April 28, 2019
Published online: May 21, 2019
Processing time: 88 Days and 13.7 Hours
Core Tip

Core tip: Administration of botulinum toxin A (BTA) in the surgical repair of ventral, incisional and complex hernia is a useful method, even for large hernia defects. The toxin is intramuscularly injected under Ultra-Sound guidance, covering all layers of the lateral abdominal muscles. The neurotoxic and analgesic activity of BTA leads to tension-free hernia closure. There is an increasing use of the technique especially in laparoscopic mesh repair. However, future data analysis will demonstrate the results and the benefits of this interesting procedure.